Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net income	$ 4,246	$ 4,885
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,081	1,092
Amortization of right of use lease assets	312	202
Accretion related to acquisition, net	22	22
Amortization of subordinated debt issuance costs	65	65
Provision for credit losses	341	737
Loss on sale of securities, net	0	164
Net amortization of securities	296	383
Decrease (increase) in loans held for sale, net	470	(596)
Net gain on disposal of premises and equipment	0	(200)
Net loss on write-down/sale of repossessed assets	36	69
Income from bank owned life insurance	(535)	(513)
Stock compensation expense	205	248
Increase in other assets	(108)	(955)
Decrease in accrued expenses and other liabilities	(1,695)	(540)
Net cash provided by operating activities	4,736	5,063
Investing activities:
Proceeds from redemption (cash used in purchases) of restricted securities, net	1,351	(1,125)
Proceeds from maturities and paydowns of available-for-sale securities	970	0
Proceeds from sales of available-for-sale securities	0	8,088
Paydowns on available-for-sale securities	9,131	7,618
Net decrease (increase) in loans held for investment	23,747	(67,920)
Purchases of premises and equipment	(1,951)	(487)
Proceeds from sale of premises and equipment	0	839
Net cash provided by (used in) investing activities	33,248	(52,987)
Financing activities:
Increase (decrease) in noninterest-bearing deposits	28,304	(73,886)
(Decrease) increase in savings deposits	(30,917)	41,758
Increase in time deposits	8,791	104,824
Decrease in federal funds purchased, repurchase agreements and other borrowings, net	(1,002)	(11,865)
Increase in Federal Home Loan Bank advances	44,336	307,850
Repayment of Federal Home Loan Bank advances	(74,200)	(284,500)
Proceeds from Employee Stock Purchase Plan issuance	59	61
Cash dividends paid on common stock	(1,416)	(1,405)
Net cash (used in) provided by financing activities	(26,045)	82,837
Net increase in cash and cash equivalents	11,939	34,913
Cash and cash equivalents at beginning of period	80,806	21,066
Cash and cash equivalents at end of period	92,745	55,979
Cash payments for:
Interest	11,724	5,646
Supplemental schedule of noncash transactions
Unrealized gains on securities available-for-sale	293	1,279
Loans transferred to repossessed assets	1,256	0
Impact of adoption of new accounting pronouncements	$ 108	$ 991